FCBT
ACAD icon

First Citizens Bank & Trust’s Acadia Pharmaceuticals ACAD Stock Holding History

First Citizens Bank & Trust’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$619K Buy
+24,482
New +$539K 0.01% 421

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

First Citizens Bank & Trust's ACAD Position: Q2 2026 in Review

First Citizens Bank & Trust opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2026: 24,482 shares worth $619K. The stake represents 0.01% of the portfolio and ranks #421 among its holdings.

354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • First Citizens Bank & Trust held 24,482 shares of Acadia Pharmaceuticals worth $619K as of Q2 2026.
  • Acadia Pharmaceuticals was a new First Citizens Bank & Trust position in Q2 2026.
  • Acadia Pharmaceuticals made up 0.01% of First Citizens Bank & Trust's portfolio in Q2 2026, its #421 holding.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.